Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide for weight loss is not a single injection dose—it's a personalized escalation plan that typically begins at 0.25 mg and increases over 16 to 20 weeks. Most patients reach their therapeutic dose between 2.0 and 2.4 mg weekly, though some require higher amounts depending on individual metabolism and treatment response. PlexusDx compounds pharmaceutical-grade semaglutide in licensed facilities and helps you navigate dosing safely without membership fees or insurance requirements.

Understanding Semaglutide Injection Dose Escalation

Semaglutide injection therapy begins with a four-week initiation phase at 0.25 mg once weekly. This low starting dose allows your body to adapt to the medication and helps your digestive system acclimate to how GLP-1 receptors signal fullness and reduce appetite. During this period, most patients experience mild nausea that typically resolves within a few days of injection.

The dose then increases by 0.25 mg every four weeks in a structured protocol. By week 12, you'll typically reach 0.75 mg; by week 16, most patients move to 1.0 mg; and by week 20, the therapeutic target of 1.5 to 2.4 mg is reached. This gradual increase is not arbitrary—clinical trials show that slower escalation improves side effect tolerance and medication adherence compared to faster dose advancement.

Some individuals plateau at 1.5 mg and achieve excellent weight loss results, while others may eventually reach 2.4 mg or higher for sustained benefit. Your prescribing provider monitors your response and adjusts timing based on your own metabolic needs, hunger levels, and any side effects you report. This personalized approach means your dose schedule is uniquely yours, not standardized.

How Many Injections Before Reaching Full Dose?

A typical semaglutide journey involves 5 to 6 injections over the first 20 weeks before you settle into a steady maintenance dose. If you start at week 1 with 0.25 mg, you'll inject weekly: one shot at 0.25 mg, then one at 0.5 mg, then one at 0.75 mg, continuing upward in 0.25 mg increments. Most patients complete this escalation phase without stopping, as long as they tolerate side effects well.

Once you reach your target dose—commonly 2.0 to 2.4 mg—you continue injecting that same amount once per week indefinitely. This maintenance phase is where sustained weight loss occurs. Patients who lose significant weight in the escalation phase often lose an additional 10 to 15 percent of their starting body weight during the first 6 months of maintenance dosing, according to real-world clinical observations.

Semaglutide Injection Pricing vs. Dose Level

PlexusDx charges a single flat monthly rate for semaglutide injection therapy: starting at $149 per month regardless of whether you're taking 0.25 mg or 2.4 mg. This means your dose may need to go up, but your price won't. No hidden per-dose increases, no tiered cost structure tied to milligram strength.

PlexusDx serves all 50 states with no insurance required, no membership fee, and HSA or FSA eligibility. Your prescription is filled by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality at a transparent price point. After your first month, you can add the Precision Peptide Genetic Test for $99 to identify genetic variants that influence how your body responds to GLP-1 therapy.

Personalized Dosing and Genetic Response Insights

Not all bodies respond to semaglutide the same way. Genetic variants in your GLP1R, GIPR, FTO, and MC4R genes influence how aggressively your appetite signals respond to GLP-1 activation. Some patients achieve excellent weight loss at lower doses, while others with different genetic profiles may need higher amounts to feel the same appetite suppression.

PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways and analyzes 49 peptides to reveal whether your genetic blueprint favors rapid GLP-1 response, slower adaptation, or baseline metabolic predispositions that affect weight loss potential. This insight helps your provider optimize your dose escalation speed and target dose level before you even begin, reducing trial-and-error adjustments and increasing your likelihood of sustained weight loss success.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

Most patients begin with 0.25 mg injected once weekly for the first four weeks. This minimal starting dose allows your body to adapt while side effects like nausea remain mild and temporary. PlexusDx providers follow evidence-based escalation protocols to reach your target dose safely.

How much weight can I expect to lose on semaglutide?

Clinical trials report average weight loss of 10 to 15 percent of starting body weight over 68 weeks with semaglutide therapy. Some patients achieve up to 20 percent weight loss with consistent dosing and lifestyle support. Individual results depend on genetics, adherence, diet, and exercise—which is why PlexusDx offers the Precision Peptide Gen...

Does PlexusDx charge more if my dose increases?

No. PlexusDx semaglutide injection pricing remains flat at $149 per month regardless of dose escalation. Your dose may need to go up, but your price won't. This applies across all three commitment tiers, making long-term weight loss treatment financially predictable.

What are common side effects during dose escalation?

Nausea, constipation, and reduced appetite are most frequent during the first 1 to 2 weeks of each dose increase. These effects typically resolve within 3 to 7 days as your body adapts. Serious side effects are rare when semaglutide is prescribed by a qualified provider and dosed gradually—slower escalation significantly reduces intolerance and ...

How does the Precision Peptide Genetic Test improve my dosing plan?

PlexusDx's genetic test identifies variants in GLP1R, GIPR, FTO, and MC4R that predict whether you'll respond quickly to low doses or require higher amounts. This $99 add-on after your first month allows your provider to personalize your escalation pace and target dose, reducing guesswork and accelerating your path to sustained weight loss.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves